• DOI:10.1007/BF03256820
Corpus ID: 31439802

EU Compassionate Use Programmes (CUPs)

@article{Sou2012EUCU,
  title={EU Compassionate Use Programmes (CUPs)},
  author={H{\'e}l{\`e}ne Sou},
  journal={Pharmaceutical Medicine},
  year={2012},
  volume={24},
  pages={223-229}
}

Hélène Sou

Published 2012

Medicine, Business

Pharmaceutical Medicine

For some patients, compassionate use programmes (CUPs) are the only way to access promising medicinal products that are not yet authorized and for which clinical trials are either not available or in which these patients cannot participate. For such patients, the CUP benefits can be very important. Although an EU regulatory framework exists, there is no single, centralized EU-wide procedure for CUPs. Each Member State has its own procedures and CUP approvals are governed by national regulatory… CONTINUE READING

View on Springer

voisinconsulting.com

Save to Library

Create Alert

Cite

Launch Research Feed